Chongqing Jihong Pharmaceutical Co., Ltd. 2026 Interim Performance Forecast

San Sheng Co., Ltd.·July 14, 2026·1 page

✨ AI Summary

Chongqing Jihong Pharmaceutical forecasts a net loss for H1 2026, attributing it to market changes impacting raw material costs and weak downstream demand. This follows the company's restructuring in late 2025, which involved divesting its building materials and overseas businesses. The company has communicated these preliminary figures with its auditors, with no major disagreements noted.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Chongqing Jihong Pharmaceutical Co., Ltd.

2026 Interim Performance Forecast

The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and are free from any false representations, misleading statements, or material omissions.

I. Interim Performance Forecast

Performance Forecast Period: January 1, 2026, to June 30, 2026.
Performance Forecast: Net profit is expected to be negative.

(1) Performance forecast by range:

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.